Literature DB >> 23184267

Predictors of margin status after breast-conserving operations in an underscreened population.

Rozbeh Torabi1, Chiu-Hsieh Hsu, Prahladbhai N Patel, Harikrishna Dave, Marcia E Bouton, Ian K Komenaka.   

Abstract

PURPOSE: Negative margins after lumpectomy remain a prominent issue in breast surgery. The current study was performed to evaluate patient-related variables that affect risk for positive margins in an underscreened population.
METHODS: A retrospective review was performed of all patients who underwent breast-conserving operations from 2001 to 2010. Sociodemographic, clinical, and treatment variables were evaluated. One millimeter from tumor to inked margin was considered a negative margin. Univariate and multivariate analyses were performed to identify variables which affect margin status after a lumpectomy.
RESULTS: Over the time period evaluated, 69 patients had positive margins (31 %) and 155 (69 %) had negative margins. Overall use of screening mammography was poor (36 %). In unadjusted analysis, patients with positive margins were less likely to have undergone screening mammography (p = 0.003) and presented with a palpable mass (p = 0.01). Histopathologic variables which predicted increased risk for positive margins included larger pathologic size, greater number of pathologically involved lymph nodes, higher pathologic stage, presence of lymphovascular invasion (LVI) and extensive intraductal component (EIC), p < 0.05. In multivariate analysis, clinical stage, poor histologic grade, LVI, and EIC were associated with positive margins (p < 0.05). By contrast, use of preoperative chemotherapy was associated with attaining negative margins (p < 0.05).
CONCLUSIONS: Factors associated with positive margins after lumpectomy included poor histologic grade, LVI, and EIC. Use of preoperative chemotherapy was the strongest independent predictor of lower risk for positive margins.

Entities:  

Mesh:

Year:  2012        PMID: 23184267     DOI: 10.1007/s00423-012-1023-8

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  34 in total

1.  Association of clinical and pathologic variables with lumpectomy surgical margin status after preoperative diagnosis or excisional biopsy of invasive breast cancer.

Authors:  Melanie C Smitt; Kate Horst
Journal:  Ann Surg Oncol       Date:  2007-01-04       Impact factor: 5.344

2.  Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized study population and data of additional patients treated with the same regimen.

Authors:  Aman U Buzdar; Vicente Valero; Nuhad K Ibrahim; Deborah Francis; Kristine R Broglio; Richard L Theriault; Lajos Pusztai; Marjorie C Green; Sonja E Singletary; Kelly K Hunt; Aysegul A Sahin; Francisco Esteva; William F Symmans; Michael S Ewer; Thomas A Buchholz; Gabriel N Hortobagyi
Journal:  Clin Cancer Res       Date:  2007-01-01       Impact factor: 12.531

3.  Surgical margin and breast recurrence after breast-conserving therapy.

Authors:  J Horiguchi; Y Iino; H Takei; M Maemura; T Yokoe; H Niibe; M Yamakawa; T Nakajima; T Oyama; Y Morishita
Journal:  Oncol Rep       Date:  1999 Jan-Feb       Impact factor: 3.906

4.  Impact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancer.

Authors:  Judy C Boughey; Florentia Peintinger; Funda Meric-Bernstam; Allison C Perry; Kelly K Hunt; Gildy V Babiera; S E Singletary; Isabelle Bedrosian; Anthony Lucci; Aman U Buzdar; Lajos Pusztai; Henry M Kuerer
Journal:  Ann Surg       Date:  2006-09       Impact factor: 12.969

5.  Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute.

Authors:  G Bonadonna; P Valagussa; C Brambilla; L Ferrari; A Moliterni; M Terenziani; M Zambetti
Journal:  J Clin Oncol       Date:  1998-01       Impact factor: 44.544

6.  Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27.

Authors:  Harry D Bear; Stewart Anderson; Roy E Smith; Charles E Geyer; Eleftherios P Mamounas; Bernard Fisher; Ann M Brown; Andre Robidoux; Richard Margolese; Morton S Kahlenberg; Soonmyung Paik; Atilla Soran; D Lawrence Wickerham; Norman Wolmark
Journal:  J Clin Oncol       Date:  2006-04-10       Impact factor: 44.544

7.  Compliance with mammography and bone mineral density screening in women at least 50 years old.

Authors:  Eric S Meadows; Albert Whangbo; Neil McQuarrie; Nisha Gilra; Beth D Mitchell; John L Mershon
Journal:  Menopause       Date:  2011-07       Impact factor: 2.953

8.  Predictors of surgical margin status in breast-conserving surgery within a breast screening program.

Authors:  Emil D Kurniawan; Matthew H Wong; Imogen Windle; Allison Rose; Arlene Mou; Malcolm Buchanan; John P Collins; Julie A Miller; Russell L Gruen; G Bruce Mann
Journal:  Ann Surg Oncol       Date:  2008-07-10       Impact factor: 5.344

9.  Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma.

Authors:  D E Wazer; T DiPetrillo; R Schmidt-Ullrich; L Weld; T J Smith; D J Marchant; N J Robert
Journal:  J Clin Oncol       Date:  1992-03       Impact factor: 44.544

10.  Cosmesis and satisfaction after breast-conserving surgery correlates with the percentage of breast volume excised.

Authors:  R A Cochrane; P Valasiadou; A R M Wilson; S K Al-Ghazal; R D Macmillan
Journal:  Br J Surg       Date:  2003-12       Impact factor: 6.939

View more
  3 in total

1.  Teaching residents may affect the margin status of breast-conserving operations.

Authors:  Gina R Shirah; Chiu-Hsieh Hsu; Meredith A Heberer; Lauren I Wikholm; Jonathan J Goodman; Marcia E Bouton; Ian K Komenaka
Journal:  Surg Today       Date:  2015-05-24       Impact factor: 2.549

2.  Does Breast Density Increase the Risk of Re-excision for Women with Breast Cancer Having Breast-Conservation Therapy?

Authors:  Siun M Walsh; Sandra B Brennan; Emily C Zabor; Laura H Rosenberger; Michelle Stempel; Lizza Lebron-Zapata; Mary L Gemignani
Journal:  Ann Surg Oncol       Date:  2019-08-08       Impact factor: 5.344

3.  Peritumoral apparent diffusion coefficients for prediction of lymphovascular invasion in clinically node-negative invasive breast cancer.

Authors:  Naoko Mori; Shunji Mugikura; Chiaki Takasawa; Minoru Miyashita; Akiko Shimauchi; Hideki Ota; Takanori Ishida; Atsuko kasajima; Kei Takase; Tetsuya Kodama; Shoki Takahashi
Journal:  Eur Radiol       Date:  2015-05-30       Impact factor: 5.315

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.